Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: A quantitative analysis

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 2135-2144

  Morrison, Paul F ^a   Morishige, Gregory M ^a   Beagles, Karen E ^a   Heyes, Melvyn P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Blood brain barrier; Efflux transport; In vivo microdialysis; Probenecid; Quinolinic acid

Indexed keywords

HOMOVANILLIC ACID; KYNURENINE; NEUROTOXIN; PROBENECID; QUINOLINIC ACID; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORPUS STRIATUM; EXTRACELLULAR FLUID; FEMALE; GERBIL; KIDNEY; LIVER LEVEL; MEMBRANE TRANSPORT; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SERUM; TISSUE HOMOGENATE;

ANIMALS; BRAIN; CARRIER PROTEINS; COMPUTER SIMULATION; CORPUS STRIATUM; EXTRACELLULAR SPACE; FEMALE; GERBILLINAE; HOMOVANILLIC ACID; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; PROBENECID; QUINOLINIC ACID;

ANIMALIA; GERBILLINAE;

EID: 0033006124     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722135.x     Document Type: Article

References (45)

1. Barany E. H. (1973a) The liver-like anion transport system in rabbit kidneys, uvea and choroid plexus. I. Selectivity of some inhibitors, direction of transport, possible physiological significance. Acta Physiol Scand. 88, 412-429.
2. Barany E. H. (1973b) The liver-like anion transport system in rabbit kidneys, uvea and choroid plexus. II. Efficiency of acid drugs and other anions as inhibitors. Acta Physiol. Scand. 88, 491-504.
3. Basile A. S., Saito K., Li Y., and Heyes M. P. (1995) The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J. Neurochem. 64, 2607-2614.
4. Beagles K. E., Morrison P. F., and Heyes M. P. (1998) Quinolinic acid in vivo synthesis rates, extracellular fluid concentrations, and intercompartmental distributions in normal and immune activated brain as determined by multiple isotope microdialysis. J. Neurochem. 70, 281-291.
5. Bergqvist P. B. F., Heyes M. P., Bugge M., and Bengtsson F. (1995) Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge. J. Neurochem. 65, 2235-2240.
6. Blight A. R., Cohen T. I., Saito K., and Heyes M. P. (1995) Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118, 735-752.
7. Boger W. P. and Pitts F. W. (1950) Plasma concentrations of p-amino-salicylic acid increased by p-(di-n-propylsulfamyl) benzoic acid. Science 112, 140-150.
8. Bradbury M. (1979) The Concept of a Blood-Brain Barrier. John Wiley & Sons, New York.
9. Bungay P. M., Morrison P. F., and Dedrick R. L. (1990) Steady state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 46, 105-119.
10. Cserr H. F. and Van Dyke D. H. (1971) 5-Hydroxyindoleacetic acid accumulation by isolated choroid plexus. Am. J. Physiol. 220, 718-723.
11. Cunningham R. F., Israili Z. H., and Dayton P. G. (1981) Clinical pharmacokinetics of probenecid. Clin. Pharmacokinet. 6, 135-151.
12. Dedek J., Baumes R., Tien-Duc N., Gomeni R., and Korf J. (1979) Turnover of free and conjugated (sulphonyloxy) dihydroxyphenylacetic acid and homovanillic acid in rat striatum. J. Neurochem. 33, 687-695.
13. Deguchi Y., Nozawa N., Yamada S., Yokoyama Y., and Kimura R. (1997) Quantitative evaluation of brain distribution and blood-brain-barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system. J. Pharmacol. Exp. Ther. 280, 551-560.
14. Dykstra K. H., Hsiao J. K., Morrison P. F., Bungay P. M., Mefford I. N., Scully M. M., and Dedrick R. L. (1992) Quantitative examination of tissue concentration profiles associated with microdialysis. J. Neurochem. 58, 931-940.
15. Flanagan E. M., Erickson J. B., Viveros O. H., Chang S. Y., and Reinhard J. F. Jr. (1995) Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J. Neurochem. 64, 1192-1196.
16. Foster A. C., Zinkand W. C., and Schwarcz R. (1985) Quinolinic acid phosphoribosyltransferase in rat brain. J. Neurochem. 44, 446-454.
17. Fukui S., Schwarcz R., Rapoport S. I., Takada Y., and Smith Q. R. (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007-2015.
18. Grant R. S. and Kapoor V. (1998) Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J. Neurochem. 70, 1759-1763.
19. Halperin J. J. and Heyes M. P. (1992) Neuroactive kynurenines in Lyme borreliosis. Neurology 42, 43-50.
20. Heyes M. P., Achim C., Wiley C. A., Major E. O., Saito K., and Markey S. P. (1996) Human microglia convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 320, 595-597.
21. Heyes M. P. and Markey S. P. (1988) Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal. Biochem. 174, 349-359.
22. Heyes M. P. and Morrison P. F. (1997) Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues. J. Neurochem. 68, 280-288.
23. Heyes M. P., Hutto B., and Markey S. P. (1988) 4-Chloro-3-hydroxyanthranilic acid inhibits 3-hydroxyanthranilic acid oxidase in brain. Neurochem. Int. 13, 405-409.
24. Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. E., Keilp J., Rubinow D., and Markey S. P. (1991a) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurologic status. Ann. Neurol. 29, 202-209.
25. Heyes M. P., Swartz K. J., Markey S. P., and Beal M. F. (1991b) Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci. Lett. 122, 265-269.
26. Heyes M. P., Saito K., Jacobowitz D., Takikawa O., Markey S. P., and Vickers J. (1992a) Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 6, 2977-2989.
27. Heyes M. P., Saito K., and Markey S. P. (1992b) Human macrophages convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 283, 633-635.
28. Heyes M. P., Saito K., Major E. O., Milstien S., Markey S. P., and Vickers J. H. (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease: attenuation of synthesis from L-tryptophan by 6-chloro-tryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116, 1425-1450.
29. Heyes M. P., Saito K., Chen C. Y., Proescholdt M. G., Nowak T. S. Jr., Li J., Beagles K. E., Proescholdt M. A., Zito M. A., Kawai K., and Markey S. P. (1997) Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes, and accumulations in response to ischemic brain injury and systemic immune activation. J. Neurochem. 69, 1519-1529.
30. Heyes M. P., Saito K., Lackner A., Wiley C. A., Achim C. L., and Markey S. P. (1998) Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J. 12, 881-896.
31. Krieger C., Hansen S., and Heyes M. P. (1994) Amyotropic lateral sclerosis: quinolinic acid levels in cerebrospinal fluid and spinal cord. Neurodegeneration 2, 237-241.
32. Morrison P. F., Bungay P. M., Hsiao J. K., Mefford I. N., Dykstra K. H., and Dedrick R. L. (1991) Quantitative microdialysis, in Microdialysis in the Neurosciences (Justice J. B. and Robinson T. E., eds), pp. 47-80. Elsevier Science Publishers, London.
33. Parsons L. H. and Justice J. B. Jr. (1992) Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J. Neurochem. 58, 212-218.
34. Perel J. M., Levitt M., and Dunner D. L. (1974) Plasma and cerebrospinal fluid probenecid concentrations as related to accumulation of acidic biogenic amine metabolites in man. Psychopharmacology (Berl.) 35, 83-90.
35. Reinhard J. F. J. (1998) Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid. Neurochem. Res. 23, 661-665.
36. Robinson M. B., Heyes M. P., Anegawa N. J., Gorry E., Djali S., and Batshaw M. L. (1992) Quinolinate in brain and cerebrospinal fluid of rat models of congenital hyperammonemia. Pediatr. Res. 32, 483-488.
37. Saito K., Markey S. P., and Heyes M. P. (1992) Effects of immune activation on quinolinic acid and kynurenine pathway metabolism in the mouse. Neuroscience 51, 25-39.
38. Saito K., Crowley J. S., Markey S. P., and Heyes M. P. (1993a) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268, 15496-15503.
39. Saito K., Nowak T. S. Jr., Markey S. P., and Heyes M. P. (1993b) Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60, 180-192.
40. Sheikh M. I. and Maxild J. (1978) Kinetic studies on the renal transport of probenecid in vitro. Biochim. Biophys. Acta 514, 356-361.
41. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309-379.
42. Tamarkin N. R., Goodwin F. K., and Axelrod J. (1970) Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397-1408.
43. Vogelgesang S. A., Heyes M. P., West S. G., Salazar A. M., Sfikakis P. P., Lipnick R. N., Klipple G. L., and Tsokos G. C. (1996) Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations. J. Rheumatol. 23, 850-855.
44. Wolfson L. I., Katzman R., and Escriva A. (1974) Clearance of amine metabolites from the cerebrospinal fluid. Neurology 24, 772-779.
45. Yates J. R., Blight A. R., Mekonnen B., and Heyes M. P. (1997) Sustained improvement following suppression of local quinolinic acid synthesis in injured spinal cord. Soc. Neurosci. Abstr. 23, 1384.